Bio Techne | TECH

Stock Price
54.41
Daily Change
1.49 2.82%
Monthly
9.10%
Yearly
-24.00%
Q3 Forecast
53.96

Peers Price Chg Day Year Date
Agilent 128.75 0.27 0.21% -6.04% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Bio-Rad Laboratories 295.43 6.00 2.07% -10.48% Sep/05
Bruker 30.83 1.04 3.49% -51.84% Sep/05
Charles River Laboratories 163.99 1.68 1.04% -12.63% Sep/05
Danaher 200.21 1.18 0.59% -24.77% Sep/05
Exact Sciences 53.81 2.40 4.67% -8.97% Sep/05
Standard Biotools 1.30 0.01 0.78% -32.99% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Illumina 98.93 1.25 1.28% -20.47% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
Merck 109.55 1.05 0.97% -35.52% Sep/06
Mettler Toledo International 1,305.71 17.92 1.39% -5.26% Sep/05
Revvity 86.64 0.94 1.10% -24.90% Sep/05
Repligen 124.56 3.98 3.30% -15.31% Sep/05
Bio Techne 54.41 1.49 2.82% -24.00% Sep/05
Thermo Fisher Scientific 492.60 3.11 0.64% -19.59% Sep/05
Waters 306.32 6.63 2.21% -6.72% Sep/05

Indexes Price Day Year Date
USND 21700 -7.31 -0.03% 30.01% Sep/05
US400 3297 16.31 0.50% 12.16% Sep/05
US500 6481 -20.59 -0.32% 19.84% Sep/05

Bio Techne traded at $54.41 this Friday September 5th, increasing $1.49 or 2.82 percent since the previous trading session. Looking back, over the last four weeks, Bio Techne gained 9.10 percent. Over the last 12 months, its price fell by 24.00 percent. Looking ahead, we forecast Bio Techne to be priced at 53.96 by the end of this quarter and at 52.63 in one year, according to Trading Economics global macro models projections and analysts expectations.

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.